A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
Moderator: Stephen Nappi, Associate VP for Technology Commercialization and Business Development, Temple University
Speakers:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
- Tom C.-C. Hu, Ph.D. MBA DABMP, Interdisciplinary Scientist/Project Officer, U.S. Department of Health & Human Services (HHS)
- Tiffany Wilson, President & CEO, University City Science Center
- Kelly Wylam, Director of Innovation Partnership, Ben Franklin Technology Partners
